DNA-PK inhibition enhances neoantigen diversity and increases T cell responses to immunoresistant tumors. Nielsen AJ, Albert GK, Sanchez A, Chen J, et al. J Clin Invest 2024;134:e180278.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nielsen AJ, Albert GK, Sanchez A, Chen J, et al. DNA-PK inhibition enhances neoantigen diversity and increases T cell responses to immunoresistant tumors. J Clin Invest 2024;134:e180278.
PMID: 39436696